v3.26.1
Accrued expenses (Tables)
12 Months Ended
Dec. 31, 2025
Veraxa Biotech A G [Member]  
Entity Information [Line Items]  
Schedule of accrued expenses
               
    December 31,
2025
    December 31,
2024
 
Personnel expenses   459,669     253,718  
Tax provision (incl. emission levies on capital band)     535,548       427,592  
Xlife share lending accrual     1,189,037       1,001,878  
Other     491,369       119,162  
Total accrued expenses   2,675,623     1,802,350